SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

VTVT

vTv Therapeutics Inc.
NASDAQHealth Care

Latest close: 26.54 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record56516 flagged findings
Reported transactions (Form 4)51since Feb 27, 2024 · and 21 other holdings
Corporate events (8-K)30since Mar 3, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…previously filed prospectus. Our Class A common stock is traded on The Nasdaq Capital Market under the symbol “VTVT.” On May 11,…”
  • 2026-05-13listing compliance noticerecentOpen filing ↗
    “…• announcement or expectation of additional financing efforts; • sales of our Class A common stock by us, our insiders or our…”
  • 2026-05-13capital return (buybacks/dividends)recentOpen filing ↗
    “…time to time in one or more offerings. Each time we offer and sell any of the securities described in the prospectus, we will provide…”
    +1 more passage from the same document
    • “…default under the indenture with respect to any series of debt securities that we may issue: • if we fail to pay interest when due…”
  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange…”
    +1 more passage from the same document
    • “…new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events. On…”
  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…Company entered into a securities purchase agreement with certain Private Placement Investors pursuant to which the Company issued…”
    +1 more passage from the same document
    • “…entered into a securities purchase agreement with certain Private Placement Investors pursuant to which the Company issued and…”
  • 2026-05-13capital return (buybacks/dividends)recentOpen filing ↗
    “…$ 8.69 * Amount includes 8,470,624 Pre-Funded Warrants and 5,243,732 Common Warrants. The Pre-Funded and Common Warrants were…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:40 on Nov 21, 2023) · 1:40 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 565)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 8, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 8.7% · event on Sep 30, 26 · amendment
  • Oct 6, 268-K ↗Current report · Bylaws or fiscal year change
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Jul 29, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 6.9% · event on Jun 30, 26 · amendment
  • Jun 29, 26Form 4 ↗Insider transaction
  • Jun 29, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 10, 26DEFA14A ↗Shareholder meeting and votes
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results
  • May 13, 268-K ↗Current report · Other events
  • Apr 28, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 16, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 5.7% · event on Apr 13, 26 · amendment
  • Mar 27, 26SCHEDULE 13G ↗Passive stake · Millennium Management LLC · 5.0% · event on Mar 24, 26
  • Mar 10, 268-K ↗Current report · Communication to the market
  • Mar 10, 268-K ↗Current report · Results
  • Mar 10, 2610-K ↗Annual report
  • Feb 26, 268-K ↗Current report · Communication to the market
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Feb 2, 268-K ↗Current report · Entered a material agreement

565 filings on record, the oldest from Jun 11, 15.

Listing the 25 most recent filings of the 565 on record.

8-Ks, explained

Stress9Structure76Governance29
  • Feb 2, 26StructureEntered a material agreement8-K 1.01 ↗
  • Sep 2, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2025show all 3hide
    • May 19, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 11, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 27, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 25, 24StructureA material agreement was terminated8-K 1.02 ↗
  • Jul 2, 24StructureEntered a material agreement8-K 1.01 ↗
  • Mar 14, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 28, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 28, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 22, 23StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Dec 19, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 1, 23StructureCompleted an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
  • Stress3 listing notices2022 – 2023show all 3hide

9 older filings not shown · The record reaches back to Aug 4, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Feb 18, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 30, 18StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 6, 18StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • May 4, 18StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 30, 17StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 9 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Srinivas Akkaraju9.9%Dec 8, 25SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Samsara BioCapital, L.P.9.9%Aug 29, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Trails Edge Capital Partners, LP9.9%Aug 29, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Raymond Debbane9.4%Sep 30, 25SCHEDULE 13G/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Millennium Management LLC8.7%Sep 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Nov 18, 24Buy$31KPAUL J SEKHRIPres, CEO and Exec Chairperson↗
  • Nov 15, 24Buy$23KPAUL J SEKHRIPres, CEO and Exec Chairperson↗
  • Nov 15, 24Buy$30KPAUL J SEKHRIPres, CEO and Exec Chairperson↗
Stock compensation, tax and giftsshow the 8 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 22, 25Compensation$1.6MSRINIVAS AKKARAJU↗
  • Sep 3, 25Compensationamount n/aBAKER BROS. ADVISORS LP↗
  • Sep 3, 25Compensationamount n/aBAKER BROS. ADVISORS LP↗
  • Mar 5, 24Otheramount n/aBAKER BROS. ADVISORS LP↗
  • Mar 5, 24Otheramount n/aBAKER BROS. ADVISORS LP↗
  • Mar 5, 24Otheramount n/aSRINIVAS AKKARAJU↗
  • Mar 5, 24Otheramount n/aSamsara BioCapital GP, LLC↗
  • Feb 27, 24Compensation$2.7MSRINIVAS AKKARAJU↗

The full record holds 11 transactions and goes back to Mar 29, 22.

Its sector and its market

vTv Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From vTv Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow vTv Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
565 documents on file, from Jun 11, 2015 to Oct 8, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.